Journal Article
Emerging Alzheimer’s Disease Treatment Paradigms: A Late-Stage Clinical Trial Review
December 27, 2024
Featured Experts: Jakub Hlávka, PhD, Mireille Jacobson, PhD
Research
All Research Featured Research
Perspective
Medicare Can Follow Blazed Trails to Revitalize Alzheimer’s Care
April 9, 2024
Featured Experts: Jakub Hlávka, PhD, Eugene Lin, MD, MS
Journal Article
Scientists without Borders: Lessons from Ukraine
July 27, 2023
Featured Experts: Jakub Hlávka, PhD
Evidence Base
COVID-19’s Total Cost to the U.S. Economy Will Reach $14 Trillion by End of 2023
May 16, 2023
Featured Experts: Jakub Hlávka, PhD
Journal Article
Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans
April 1, 2023
Featured Experts: Jakub Hlávka, PhD
Journal Article
Macroeconomic Consequences of the COVID-19 Pandemic
January 10, 2023
Featured Experts: Jakub Hlávka, PhD
Journal Article
Cost-Effectiveness Models for Alzheimer’s Disease and Related Dementias: IPECAD Modeling Workshop Cross-Comparison Challenge
October 25, 2022
Featured Experts: Jakub Hlávka, PhD, Bryan Tysinger, PhD
Evidence Base
Bumpy Road Ahead for Lecanemab Approval
October 5, 2022
Featured Experts: Jakub Hlávka, PhD
Journal Article
Access to Disease-Modifying Alzheimer’s Therapies: Addressing Possible Challenges Using Innovative Payment Models
July 5, 2022
Featured Experts: Jakub Hlávka, PhD, Bryan Tysinger, PhD, Darius Lakdawalla, PhD
Journal Article
Addressing Challenges to Alternative Payment Models for New Alzheimer’s Disease Therapies for US Commercial Payers
May 13, 2022
Featured Experts: Jakub Hlávka, PhD
Journal Article
Impact of Non-Binding FDA Guidances On Primary Endpoint Selection in Alzheimer’s Disease Trials
March 24, 2022
Featured Experts: Jakub Hlávka, PhD, Darius Lakdawalla, PhD
Evidence Base
It is Time for the U.S. to Create a National COVID-19 Vaccination Registry
August 30, 2021
Featured Experts: Jakub Hlávka, PhD
Journal Article
Clinical Outcome Measure Crosswalks in Alzheimer’s Disease: A Systematic Review
August 6, 2021
Featured Experts: Jakub Hlávka, PhD
Journal Article
The Economics of Alternative Payment Models for Pharmaceuticals
March 16, 2021
Featured Experts: Jakub Hlávka, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Perspective
Travel Bans Should Be Based on Evidence, Not Politics or Fear
January 25, 2021
Featured Experts: Jakub Hlávka, PhD
Journal Article
Blood‐Based Biomarkers for Alzheimer’s Pathology and the Diagnostic Process for a Disease‐Modifying Treatment: Projecting the Impact on the Cost and Wait Times
August 19, 2020
Featured Experts: Jakub Hlávka, PhD
White Paper
Prospects for Future Advances in Alzheimer’s Disease
August 18, 2020
Featured Experts: Jakub Hlávka, PhD, Dana Goldman, PhD
Evidence Base
How Can We Leverage Healthcare AI While Ensuring Data Privacy and Security?
July 15, 2020
Featured Experts: Jakub Hlávka, PhD
Evidence Base
International Travel Restrictions During a COVID-19 Pandemic
May 20, 2020
Featured Experts: Jakub Hlávka, PhD